RADIOLOGICAL PREDICTIVE REMISSION FACTORS OF PULMONARY INVOLVEMENT IN SYSTEMIC SARCOIDOSIS: A COMPUTED TOMOGRAPHY SCAN STUDY

被引:0
|
作者
Kechida, Melek [1 ,3 ]
Abdelali, Mabrouk [2 ]
Mesfar, Rym [1 ]
Chaabene, Imene [1 ]
Klii, Rim [1 ]
Hammami, Sonia [1 ]
Daadaa, Syrine [1 ]
Maatouk, Mezri [2 ]
Saad, Jamel [2 ]
Zrig, Ahmed [2 ]
Khochtali, Ines [1 ]
机构
[1] Univ Monastir, Fattouma Bourguiba Univ Hosp, Internal Med & Endocrinol Dept, Monastir, Tunisia
[2] Univ Monastir, Fattouma Bourguiba Univ Hosp, Radiol Dept A, Monastir, Tunisia
[3] Fattouma Bourguiba Univ Hosp, Internal Med & Endocrinol Dept, Monastir, Tunisia
关键词
sarcoidosis; pulmonary manifestations; computed tomography scan; HIGH-RESOLUTION CT; MANIFESTATIONS;
D O I
10.36141/svdld.v40i4.15118
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: As little is known about the prognostic value of CT scan findings at onset in patients presenting with sarcoidosis, we aimed to identify factors independently associated with radiological remission of pulmonary involvement in systemic sarcoidosis on CT scan findings. Methods: We conducted a retrospective descriptive and analytic study of patients with biopsy-proven systemic sarcoidosis. We compared patients on radiological remission (group 1) to those on stabilization or progression (group 2). Multivariate analysis of variables significantly associated with radiological remission in univariate analysis was performed using binary logistic regression. Results: Out of 65 records of systemic sarcoidosis, 43 were analyzed. 18.6% were male and 81.6% were female, with a sex ratio of 0.22 and a mean age at diagnosis of 47.2 +/- 13.6 years. We found atypical lesions in CT scan findings in 16 patients (37.2%). Comparative pulmonary CT scan findings at admission and at 12-month follow-up revealed 13 patients (30.2%) in remission (group 1) and 30 patients in radiological stabilization or progression (group 2). On multivariate analysis, lymphopenia, calcifications, and typical CT scan findings at presentation were predictive factors of remission of pulmonary involvement in systemic sarcoidosis (aOR = 27.57; 95% CI = 2.67-284.63; p = 0.005), (37.2; 95% CI = 2.08-663.89; p = 0.014), and (47.1; 95% CI = 1.79-1238.5; p = 0.021), respectively. Conclusion: In patients with symptomatic systemic sarcoidosis with no lymphopenia at onset, calcifications, or typical CT scan findings at presentation, we suggest a close follow-up as well as an intensive treatment.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] A role of interim positron emission tomography/computed tomography scan in the management of Hodgkin lymphoma: A single-center study in a developing country
    Azeez, Saya
    Yassin, Ahmed Khudair
    Mohammad, Nawsherwan S.
    Hassan, Kawa M.
    Mohamed, Zeki A.
    Polus, Ranan Kardagh
    Khudhur, Hawar Gh
    IRAQI JOURNAL OF HEMATOLOGY, 2022, 11 (02) : 118 - 124
  • [42] A Comparison Study of Lymph Node Tuberculosis and Sarcoidosis Involvement to Facilitate Differential Diagnosis and to Establish a Predictive Score for Tuberculosis
    Hoornaert, Ellen
    Yildiz, Halil
    Pothen, Lucie
    De Greef, Julien
    Gheysens, Olivier
    Kozyreff, Alexandra
    Castanares-Zapatero, Diego
    Yombi, Jean Cyr
    PATHOGENS, 2024, 13 (05):
  • [43] Risk Factors for Early Return Visits to the Emergency Department in Patients Presenting with Nonspecific Abdominal Pain and the Use of Computed Tomography Scan
    Yau, Fei-Fei Flora
    Yang, Ying
    Cheng, Chi-Yung
    Li, Chao-Jui
    Wang, Su-Hung
    Chiu, I-Min
    HEALTHCARE, 2021, 9 (11)
  • [44] Efficacy and safety of Infliximab in systemic sarcoidosis according to GenPhenReSa organ-involvement phenotype: a retrospective study of 55 patients
    Etienne Rivière
    Wendy Jourde
    Noémie Gensous
    Xavier Demant
    Emmanuel Ribeiro
    Pierre Duffau
    Patrick Mercié
    Jean-François Viallard
    Estibaliz Lazaro
    Respiratory Research, 25
  • [45] Efficacy and safety of Infliximab in systemic sarcoidosis according to GenPhenReSa organ-involvement phenotype: a retrospective study of 55 patients
    Riviere, Etienne
    Jourde, Wendy
    Gensous, Noemie
    Demant, Xavier
    Ribeiro, Emmanuel
    Duffau, Pierre
    Mercie, Patrick
    Viallard, Jean-Francois
    Lazaro, Estibaliz
    RESPIRATORY RESEARCH, 2024, 25 (01)
  • [46] Pulmonary function tests, high-resolution computerized tomography, α1-antitrypsin measurement, and early detection of pulmonary involvement in patients with systemic sclerosis
    Shahin, AA
    Sabri, YY
    Mostafa, HA
    Sabry, EY
    Hamid, MA
    Gamal, H
    Shahin, HA
    RHEUMATOLOGY INTERNATIONAL, 2001, 20 (03) : 95 - 100
  • [47] Lung ultrasound in systemic sclerosis: correlation with high-resolution computed tomography, pulmonary function tests and clinical variables of disease
    Gigante, Antonietta
    Fanelli, Filippo Rossi
    Lucci, Silvio
    Barilaro, Giuseppe
    Quarta, Silvia
    Barbano, Biagio
    Giovannetti, Antonello
    Amoroso, Antonio
    Rosato, Edoardo
    INTERNAL AND EMERGENCY MEDICINE, 2016, 11 (02) : 213 - 217
  • [48] Lung ultrasound in systemic sclerosis: correlation with high-resolution computed tomography, pulmonary function tests and clinical variables of disease
    Antonietta Gigante
    Filippo Rossi Fanelli
    Silvio Lucci
    Giuseppe Barilaro
    Silvia Quarta
    Biagio Barbano
    Antonello Giovannetti
    Antonio Amoroso
    Edoardo Rosato
    Internal and Emergency Medicine, 2016, 11 : 213 - 217
  • [49] Systemic sclerosis: correlation between lung abnormalities on high-resolution computed tomography (HRCT) and pulmonary function tests (PFTs)
    Iman Mohamed Hamdy Ibrahim
    Sherif Mohamed Gamal
    Adham Mamdouh Salama
    Mostafa Ahmed Khairy
    Egyptian Journal of Radiology and Nuclear Medicine, 51
  • [50] FLT-PET for the assessment of systemic sarcoidosis including cardiac and CNS involvement: a prospective study with comparison to FDG-PET
    Patrick Martineau
    Matthieu Pelletier-Galarneau
    Daniel Juneau
    Eugene Leung
    Pablo Nery
    Rob deKemp
    Rob Beanlands
    David Birnie
    EJNMMI Research, 10